株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

欧州の経カテーテル大動脈弁留置術 (TAVI) 市場:販売数量、平均販売価格、予測

Transcatheter Aortic Valve Implantation Market | Europe | Units Sold, Average Selling Prices, Forecasts | 2018-2024| MedCore

発行 iData Research Inc. 商品コード 718249
出版日 ページ情報 英文 344 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.43円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
欧州の経カテーテル大動脈弁留置術 (TAVI) 市場:販売数量、平均販売価格、予測 Transcatheter Aortic Valve Implantation Market | Europe | Units Sold, Average Selling Prices, Forecasts | 2018-2024| MedCore
出版日: 2018年08月01日 ページ情報: 英文 344 Pages
概要

当レポートでは、欧州の経カテーテル大動脈弁留置術 (TAVI) 市場について調査分析し、疾患の概要、市場分析と予測、促進要因と阻害要因、競合市場シェア分析について、体系的な情報を提供しています。

エグゼクティブサマリー

欧州の心臓手術デバイス市場の概要

競合分析

市場動向

市場の発展

処置件数

対象市場

主な調査アップデート

バージョン履歴

第1章 調査手法

第2章 疾患の概要

  • 基本構造
  • 疾患の概要
    • 冠動脈疾患
    • 心筋梗塞
    • 狭心症
    • 心臓弁疾患
    • 鬱血性心不全

第3章 経カテーテル大動脈弁留置術 (TAVI) 市場

  • イントロダクション
  • 市場分析と予測
  • 促進要因と阻害要因
    • 市場促進要因
    • 市場阻害要因
  • 競合市場シェア分析

略語

付録

図表

LIST OF CHARTS

  • Chart 1 1: Cardiac Surgery Device Market by Segment, Europe, 2014 - 2024
  • Chart 1 2: Cardiac Surgery Device Market Overview, Europe, 2017 & 2024
  • Chart 3 1: Transcatheter Aortic Valve Implantation Market, Europe, 2014 - 2024
  • Chart 3 2: Leading Competitors, Transcatheter Aortic Valve Implantation Market, Europe, 2017

LIST OF FIGURES

  • Figure 1 1: Cardiac Surgery Device Market Share Ranking by Segment, Europe, 2017 (1 of 4)
  • Figure 1 2: Cardiac Surgery Device Market Share Ranking by Segment, Europe, 2017 (2 of 4)
  • Figure 1 3: Cardiac Surgery Device Market Share Ranking by Segment, Europe, 2017 (3 of 4)
  • Figure 1 4: Cardiac Surgery Device Market Share Ranking by Segment, Europe, 2017 (4 of 4)
  • Figure 1 5: Companies Researched in this Report, Europe, 2017
  • Figure 1 6: Factors Impacting the Cardiac Surgery Device Market by Segment, Europe (1 of 4)
  • Figure 1 7: Factors Impacting the Cardiac Surgery Device Market by Segment, Europe (2 of 4)
  • Figure 1 8: Factors Impacting the Cardiac Surgery Device Market by Segment, Europe (3 of 4)
  • Figure 1 9: Factors Impacting the Cardiac Surgery Device Market by Segment, Europe (4 of 4)
  • Figure 1 10: Recent Events in the Cardiac Surgery Device Market, Europe, 2015 - 2018
  • Figure 1 11: Cardiac Surgery Procedures Covered, Europe, 2017 (1 of 2)
  • Figure 1 12: Cardiac Surgery Procedures Covered, Europe, 2017 (2 of 2)
  • Figure 1 13: Cardiac Surgery Device Markets Covered, Europe, 2017
  • Figure 1 14: Key Report Updates
  • Figure 1 15: Version History
  • Figure 3 1: Transcatheter Aortic Valve Implantation Market, Europe, 2014 - 2024
  • Figure 3 2: Units Sold by Country, Transcatheter Aortic Valve Implantation Market, Europe, 2014 - 2024
  • Figure 3 3: Average Selling Price by Country, Transcatheter Aortic Valve Implantation Market, Europe, 2014 - 2024 (€)
  • Figure 3 4: Average Selling Price by Country, Transcatheter Aortic Valve Implantation Market, Europe, 2014 - 2024 (US$)
  • Figure 3 5: Market Value by Country, Transcatheter Aortic Valve Implantation Market, Europe, 2014 - 2024 (€M)
  • Figure 3 6: Market Value by Country, Transcatheter Aortic Valve Implantation Market, Europe, 2014 - 2024 (US$M)
  • Figure 3 7: Drivers and Limiters, Transcatheter Aortic Valve Implantation Market, Europe, 2017
  • Figure 3 8: Leading Competitors, Transcatheter Aortic Valve Implantation Market, Europe, 2017
  • Figure 5 1: Press Release Summary
目次
Product Code: iDATA_EUCS18_MC_TAVI

The primary method for treating aortic heart valve conditions is through the use of open surgery to place a replacement valve. Biological tissue valves can be allografts (donated by other people after they die), xenografts (porcine valves) or autografts (using the patient's own pulmonary valve, which in turn, need to be replaced).

TAVI in Europe is approved for the treatment of severe aortic stenosis for symptomatic patients at intermediate, high or extreme risk for open heart surgery. Low-risk patients represent the next frontier in the TAVI market. Expansion into the low-risk population may prove to be more challenging than the higher-risk populations, which could cause TAVI sales to moderate over the forecast period.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN CARDIAC SURGERY DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
  • 2.2. DISEASE OVERVIEW
    • 2.2.1. Coronary Artery Disease
    • 2.2.2. Myocardial Infarction
    • 2.2.3. Angina Pectoris
    • 2.2.4. Heart Valve Disease
    • 2.2.5. Congestive Heart Failure

TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET

  • 3.1. INTRODUCTION
  • 3.2. MARKET ANALYSIS AND FORECAST
  • 3.3. DRIVERS AND LIMITERS
    • 3.3.1. Market Drivers
    • 3.3.2. Market Limiters
  • 3.4. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

Back to Top